Newman Dignan & Sheerar, Inc. Oragenics Inc Transaction History

Newman Dignan & Sheerar, Inc.

  • $386 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022
BUY
$0.23 - $14.18 $2,407 - $148,436
10,468 New
10,468 $2,000
Q2 2022

Aug 03, 2022
SELL
$0.24 - $0.42 $2,512 - $4,396
-10,468 Closed
0 $0
Q3 2021

Oct 07, 2021
BUY
$0.58 - $0.84 $6,071 - $8,793
10,468 New
10,468 $7,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $36.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Newman Dignan & Sheerar, Inc. Portfolio

Follow Newman Dignan & Sheerar, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email